Blog Elements

Half Sized Blog Element (Single Author Style)

Half Sized Blog Element (Multi Author Style)

Spectrum of Bone and Soft Tissue Tumors in A Tertiary Cancer Institute in Eastern India

July 10, 2018

Vol 4 | Issue 2 | July-Dec 2018 | Page 7-10 | Ashwini Natekar, Gaurav Gupta, Subhasis Basu. Authors: Ashwini Natekar [1], Gaurav Gupta [1], Subhasis Basu [1]. [1] Dept of Pathology, Chittaranjan national cancer institute, Kolkata, India Address of Correspondence Dr. Ashwini Natekar, Dept of Pathology, Chittaranjan national cancer institute, Kolkata, India Abstract Introduction: […]

Guest Editorial – Asia Pacific Musculoskeletal Tumor Society Conference 2018

July 10, 2018

Vol 4 | Issue 2 | July-Dec 2018 | page: 2-3 | Ajay Puri. Author: Ajay Puri [1]. [1] Orthopedic Oncology Services, Department of Surgical Oncology, Tata Memorial Hospital, Mumbai. Address of Correspondence Dr. Ajay Puri, Department of Orthopaedic Oncology, Room No: 26, Tata Memorial Hospital, Borges Road, Parel, Mumbai – 400 012. India. Email: […]

Spectrum of Bone and Soft Tissue Tumors in A Tertiary Cancer Institute in Eastern India

July 10, 2018

Guest Editorial – Asia Pacific Musculoskeletal Tumor Society Conference 2018

July 10, 2018

Full Sized Blog Element (Big Preview Pic)

Spectrum of Bone and Soft Tissue Tumors in A Tertiary Cancer Institute in Eastern India

July 10, 2018

Vol 4 | Issue 2 | July-Dec 2018 | Page 7-10 | Ashwini Natekar, Gaurav Gupta, Subhasis Basu.

Authors: Ashwini Natekar [1], Gaurav Gupta [1], Subhasis Basu [1].

[1] Dept of Pathology, Chittaranjan national cancer institute, Kolkata, India

Address of Correspondence
Dr. Ashwini Natekar,
Dept of Pathology, Chittaranjan national cancer institute, Kolkata, India

Abstract

Introduction: Bone and soft tissue tumours are uncommon tumours that can affect any age group. Soft tissue tumors are said to be heterogeneous group of mesenchymal malignancies. Primary bone sarcomas are rare tumors, comprising approximately 0.2% of all cancers. Their true incidence is difficult to estimate because of their rarity.[1]The outcome of the disease depends on the age and time at diagnosis.
Material and Methods: A study was carried out in department of pathology in tertiary cancer institute in East India from December 2015 to September 2017. A total of 60 cases were included in the study. Clinical and radiological details of patients were noted along with gross specimen findings and microscopic examination of H &E stained slides. IHC was also carried out for confirmatory diagnosis.
Aims and Objecctives: 1- To study the histological spectrum of bone and soft tissue tumors in a tertiary cancer institute in Eastern India
2- To study gender distribution and site distributionof bone and soft tissue tumors
Results: Out of the total 60 cases studied 24 cases were of bone and cartilaginous tumours and 36 cases included were of soft tissue tumors. Benign tumors comprised of 08 cases (13.3%) and malignant tumors accounted to 52 cases (86.7%). Age of the patients ranged from 10 to 80 years. Male female ratio was 1.4:1.
Conclusion: Multimodal therapies of treatment is practiced for bone and soft tissue tumors. Early detection and treatment is essential for diagnosis of these malignant tumors. Molecular studies are most important in diagnosing, classifying and also prognosticating bone and soft tissue tumors.
Keywords: bone tumors, soft tissue tumors, histology.

References

1. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, et al., editors. SEER Cancer Statistics Review. Bethesda, MD: National Cancer Institute; 1975-2013. [Last accessed on 2016 Jun 01].
2. Jain P, Shrivastava A, Mallik R..Clinicomorphological Assessment of Soft Tissue Tumors. Sch J App Med Sci. 2014; 2(2D): p. 886-90.
3. Hassawi BA, Suliman AY, Hasan IS. Soft tissue tumours – Histopathological study of 93 cases. Ann Coll Med Mo sul.2-010; 36(1&2) : p. 92-8.
4. Weiss SW, Goldblum JR. General Considerations. In Enzinger & Weiss’s Soft Tissue Tumours, 4th edition.: Mosby Publication 2001; 20011-19.
5. Beg S, Vasenwala SM, Haider N, Ahmad SS,Maheshwari V, Khan MA. A comparison of cytological ad histopathological findings and role of immunostains in the diagnosis of soft tissue. J Cytol. 2012; 29(2): p. 125-130.
6. Lazim AF, Bedoor AK, Al-Irhayim. Soft tissue sarcomas in Mosul: a pathologic evaluation. Ann Coll Med Mosul. 20-08;34(2): p. 152-160.
7. Zhi-wei F, Jing C, Sheng T, Yong C, Rui-feng X. Analysis of soft tissue sarcomas in 1118 cases. Chinese Medical Journal.2009; 122(1): p. 51-53.
8. Batra P, Gupta DO, Batra R, Kothari R, Bokariya P.Pattern of Soft Tissue Tumours In A Rural Population Of Central India.Innovative Journal of Medical and Health Science. 2013 May – June; 3(3): p. 124-6.
9. Anant Ramaswamy, Bharat Rekhi,1 Sameer Bakhshi,2 Sachin Hingmire,3 and Manish Agarwal4Indian data on bone and soft tissue sarcomas: A summary of published study resultsSouth Asian Journal of Cancer.
10. Mark A. Applebaum, et al; Clinical features and outcomes in patients with extraskeletal Ewing sarcoma Cancer. 2011 Jul 1; 117(13): 3027–3032.
11. Askin FB, Rosai J, Sibley RK, Dehner LP, Mc Alister WH. Malignant small cell tumour of the thoracopulmonary region in childhood: a distinctive clinicopathologic entity of uncertain histogenesis. Cancer. 1979;43:2438–2451. doi: 10.1002/1097-0142(197906)43:6<2438::AID-CNCR2820430640>3.0.CO;2-9. [PubMed] [Cross Ref]
12. Sabati JM, Franquet T, Parellada JA, Monill JM, Oliva E. Malignant neuroectodermal tumour of the chest wall (Askin tumour): CT and MR findings in eight patients. Clinical Radiology. 1994;49:634–638. doi: 10.1016/S0009-9260(05)81882-3. [PubMed] [Cross Ref]
13. Winer-Muram HT, Kaufman WH, Gronemeyer SA, Gregory JS. Primitive neuroectodermal tumors of the chest wall (Askin tumors). CT and MR findings. Am J Res. 1985;145:517–520.
14. Dewan M, Malatani TS, Ansari MA. Lessons to be learned: A case study approach Malignant melanoma of soft tissue. J R Soc Health. 2005;125:42–6. [PubMed]
15. Crowson A, Magro C, Mihm M. Unusual histologic and clinical variants of melanoma: Implications for therapy. Curr Oncol Rep. 2007;9:403–10. [PubMed]
16 Lucas DR, Nascimento AG, Sim FH. Cell sarcoma of soft tissues: Mayo Clinic experience with 35 cases. Am J Surg Pathol. 1992;16:1197–204. [PubMed]
17. Enzinger FM. Clear cell sarcoma of tendons and aponeuroses: An analysis of 21 cases. Cancer. 1965;18:1163–76. [PubMed]
18. AF Mavrogenis,1 G Bianchi,2 NA Stavropoulos,1 PJ Papagelopoulos,1 and P Ruggieri2 Clinicopathological features, diagnosis and treatment of clear cell sarcoma/melanoma of soft parts Hippokratia. 2013 Oct-Dec; 17(4): 298–302.
19. Meis Kindblom JM. Clear cell sarcoma of tendons and aponeuroses: A historical perspective and tribute to the man behind the entity. Adv Anat Pathol. 2006;13:286–92. [PubMed]
20. O. Hocar,1 A. Le Cesne,2 S. Berissi,1 P. Terrier,2 S. Bonvalot,2 D. Vanel,3 A. Auperin,4 C. Le Pechoux,2 B. Bui,5 J. M. Coindre,5 and C. Robert1Clear Cell Sarcoma (Malignant Melanoma) of Soft Parts: A Clinicopathologic Study of 52 Cases:Dermatology Research and Practice

How to Cite this article: Ashwini Natekar A, Gupta G, Basu S. Spectrum of Bone and Soft Tissue Tumors in A Tertiary Cancer Institute in Eastern India. Journal of Bone and Soft Tissue Tumors July – Dec 2018;4(2): 7-10.

(Abstract Full Text HTML) (Download PDF)

Guest Editorial – Asia Pacific Musculoskeletal Tumor Society Conference 2018

July 10, 2018

Vol 4 | Issue 2 | July-Dec 2018 | page: 2-3 | Ajay Puri.

Author: Ajay Puri [1].

[1] Orthopedic Oncology Services, Department of Surgical Oncology, Tata Memorial Hospital, Mumbai.

Address of Correspondence
Dr. Ajay Puri,
Department of Orthopaedic Oncology, Room No: 26, Tata Memorial Hospital, Borges Road, Parel, Mumbai – 400 012. India.
Email: docpuri@gmail.com

Asia Pacific Musculoskeletal Tumor Society Conference 2018

For advances in musculo skeletal oncology to occur we need a host of clinical specialties along with nursing, rehabilitation and support staff interacting on a continuous basis. Sarcomas are rare and each individual and institution can only benefit from having access to pooled information and experience. For sarcoma care to evolve, ideas to surface and multi institute or multi-disciplinary collaborations to develop in the fields of basic research, patient care, biomaterials and prosthesis, there is a need for a common platform where all of us involved in the treatment of sarcomas can interact. Our socio economic milieu in the Asia Pacific region is unique. We have a spectrum ranging from resource rich societies with extensive state supported health care to resource constrained nations where patients have inconsistent access to health care and funding for health care is limited. Solutions and protocols applicable to the Western world need not necessarily be the most suitable in our scenario. Our large numbers coupled by the sheer native ingenuity necessary to offer quality health care in a resource challenged population can help us develop solutions that can be adapted everywhere.

The Asia Pacific Musculoskeletal Tumor Society (APMSTS) was conceptualized during discussions at the 7th International Symposium of Limb Salvage Surgeons (ISOLS) meeting in 1993 and its first meeting was held in 1995 in Japan under the stewardship of Professor Yoshio Ogihara. Mirroring a similar initiative, the Indian Musculo Skeletal Oncology Society (IMSOS) was established in 2013 to “promote scientific, evidence based, comprehensive multidisciplinary management of bone and soft tissue sarcomas and encourage basic and clinical research”. This year Jaipur, India plays host to the 12th APMSTS meeting in October. This is a joint meeting co-hosted with IMSOS. The theme of the conference is “Education – Collaboration – Innovation”. This epitomizes our desire to share and disseminate knowledge, the spirit of collaboration necessary to find answers to common problems and the need to derive innovative solutions best suited to our socio economic milieu.

The conference logo depicts the feathers of the peacock in the Indian national colours adorning a group of people with interlinked arms who represent the collaboration and camaraderie between individuals and countries that form the Asia Pacific Musculoskeletal Society. The logo represents the beauty and spirituality of India while signifying the desire to showcase skills from the Asia Pacific region. The peacock, the national bird of India symbolizes many of the qualities that we as “healers” must inculcate. In Hinduism, the peacock is associated with Saraswati the goddess of wisdom and learning. In Buddhism, the peacock is a symbol of purity and the ‘eyes’ in the peacock’s tail represent a symbol of watchfulness. The figure of the peacock is painted in various Islamic religious buildings while in Christianity the peacock was known as the symbol of resurrection and renewal. Just as the peacock elegantly unfolds its vibrant colours during its ritual dance, so too this conference is an occasion for us to demonstrate the best from all participating delegates.

We have more than 300 delegates from 28 countries participating in this meeting. Deviating from the accepted norm of didactic lectures the meeting focusses more on interactive sessions that will promote healthy discussion. There are case based panel discussions and sessions where senior musculoskeletal oncologists share their diverse experiences so that all attendees can benefit from the collective experience of others in order to enable them to make better decisions when managing similar cases. While providing adequate sessions for free papers there are two “show piece” orations. The IMSOS oration “Lessons learned from the European-American Osteosarcoma Study EURAMOS1” will be delivered by Prof. Stefan Bielack while the inaugural APMSTS “Prof. Yoshio Ogihara Oration” will be delivered by Dr. Suresh Nathan. The conference is preceded by multidisciplinary workshops that encompass all specialties involved in sarcoma care, offering delegates an opportunity to interact with faculty in smaller groups.

This unique joint meeting also offers the ideal platform to unveil a brief monograph “IMSOS guidelines for musculoskeletal sarcomas”, IMSOS’s endeavour to standardise the management of musculoskeletal sarcomas in India.

All our efforts are ultimately focussed on improving health care for our patients. A meeting such as this would be incomplete unless we involved them too. The IMSOS sarcoma support initiative will simultaneously conduct a parallel session that helps patients share their experience and presents an occasion where we can felicitate support personnel who selflessly give their time to enable us to optimise overall patient care.

We are sure the ambience and hospitality of Jaipur combined with an exciting and informative scientific programme will make this joint APMSTS – IMSOS conference a memorable and enriching event for all delegates.
It is our pleasure and privilege to welcome all attendees to Jaipur to partake of the experience that is “Incredible India”!

Prof. Ajay Puri
President – Indian Musculo Skeletal Oncology Society
President – Asia Pacific Musculoskeletal Tumor Society

How to Cite this article: Puri A. Asia Pacific Musculoskeletal Tumor Society 2018 Issue. Journal of Bone and Soft Tissue Tumors July-Dec 2018; 4(2):2-3.

(Abstract Full Text HTML) (Download PDF)

Half Sized Blog Element (Single Author Style)

Half Sized Blog Element (Multi Author Style)

Spectrum of Bone and Soft Tissue Tumors in A Tertiary Cancer Institute in Eastern India

Like this:

Guest Editorial – Asia Pacific Musculoskeletal Tumor Society Conference 2018

Like this:

Spectrum of Bone and Soft Tissue Tumors in A Tertiary Cancer Institute in Eastern India

Like this:

Guest Editorial – Asia Pacific Musculoskeletal Tumor Society Conference 2018

Like this:

Full Sized Blog Element (Big Preview Pic)

Spectrum of Bone and Soft Tissue Tumors in A Tertiary Cancer Institute in Eastern India

Authors: Ashwini Natekar [1], Gaurav Gupta [1], Subhasis Basu [1].

Abstract

References

(Abstract Full Text HTML) (Download PDF)

Like this:

Guest Editorial – Asia Pacific Musculoskeletal Tumor Society Conference 2018

Author: Ajay Puri [1].

Asia Pacific Musculoskeletal Tumor Society Conference 2018

Like this:

Like this:

Journal of Bone and Soft Tissue Tumors (JBST) Editorial Office

Important Information

Journal of Bone and Soft Tissue Tumors (JBST) License

Half Sized Blog Element (Single Author Style)

Half Sized Blog Element (Multi Author Style)

Like this:

Like this:

Like this:

Like this:

Full Sized Blog Element (Big Preview Pic)

Authors: Ashwini Natekar [1], Gaurav Gupta [1], Subhasis Basu [1].

Abstract

References

(Abstract Full Text HTML) (Download PDF)

Like this:

Author: Ajay Puri [1].

Asia Pacific Musculoskeletal Tumor Society Conference 2018

Like this:

Share this:

Like this:

Journal of Bone and Soft Tissue Tumors (JBST) Editorial Office

Important Information

Journal of Bone and Soft Tissue Tumors (JBST) License